U.S. markets closed
  • S&P 500

    4,228.48
    -55.26 (-1.29%)
     
  • Dow 30

    33,706.74
    -292.30 (-0.86%)
     
  • Nasdaq

    12,705.21
    -260.13 (-2.01%)
     
  • Russell 2000

    1,957.35
    -43.38 (-2.17%)
     
  • Crude Oil

    89.91
    -0.59 (-0.65%)
     
  • Gold

    1,760.30
    -10.90 (-0.62%)
     
  • Silver

    18.97
    -0.50 (-2.56%)
     
  • EUR/USD

    1.0044
    -0.0048 (-0.47%)
     
  • 10-Yr Bond

    2.9890
    +0.1090 (+3.78%)
     
  • GBP/USD

    1.1823
    -0.0109 (-0.92%)
     
  • USD/JPY

    136.9300
    +1.0680 (+0.79%)
     
  • BTC-USD

    21,160.38
    -1,630.60 (-7.15%)
     
  • CMC Crypto 200

    504.88
    -36.72 (-6.78%)
     
  • FTSE 100

    7,550.37
    +8.52 (+0.11%)
     
  • Nikkei 225

    28,930.33
    -11.81 (-0.04%)
     

Spectra7 Announces $8.0 Million Convertible Debenture Financing; Closing of First Tranche

  • Oops!
    Something went wrong.
    Please try again later.
·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OF DISSEMINATION IN THE UNITED STATES

TORONTO, July 26, 2022 /CNW/ -- (TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announced today a proposed non-brokered private placement basis (the "Offering") up to $8.0 million of 14% unsecured convertible debentures (the "Debentures") and the closing of the first tranche of the Offering consisting of the issuance of $3,809,000 principal amount of Debentures for gross proceeds of $3,732,820. All dollar amounts referenced in this release are in Canadian dollars.

(PRNewsfoto/Spectra7 Microsystems Inc.)
(PRNewsfoto/Spectra7 Microsystems Inc.)

Each $1,000 principal amount of Debentures will be sold at a subscription price of $980 for expected gross proceeds of up to $7,840,000. The Debentures shall mature on December 31, 2024 (the "Maturity Date") and the principal amount of each Debenture will be convertible into common shares of the Company (each, a "Common Share") at the option of the holder at any time prior to the close of business on the last business day immediately preceding the Maturity Date, at a conversion price of $1.02 per Common Share, subject to adjustment upon certain customary events. Holders converting their Debentures will receive accrued and unpaid interest thereon for the period from and including the date of the latest interest payment date to, and including, the date of conversion.

The net proceeds from the Offering will be used for the repayment of the existing convertible debentures of the Company.

All securities issuable in the Offering are subject to a statutory hold period until the date that is four months and one day from the date of issuance. Approval of the TSX Venture Exchange is required prior any conversion of Debentures that would result in a holder holding more than 9.9% of the issued and outstanding common shares of the Corporation and prior to the settlement of any interest payment in common shares. The second tranche of the Offering is expected to close on or before August 25, 2022.

Insiders of the Company participated in the first tranche of the Offering purchasing an aggregate of $506,000 principal amount of Debentures. Pursuant to Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"), the Offering constitutes a "related party transaction" as insiders of the Company are expected to subscribe for up to 25% of the Debentures. The Company is relying on exemptions from the formal valuation and minority approval requirements of MI 61-101. The Company did not file a material change report more than 21 days before the closing of the Offering as the details of the related parties' participation in the Offering had not been settled. The Offering was approved by all of the independent directors of the Company.

The Company paid finder's fees totaling $47,373 and issued 118,055 finder's warrants (each, a "Finder's Warrant") to arm's length parties, including Cormark Securities Inc., in connection with the first tranche of the Offering. Each Finder's Warrant entitles the holder to purchase one Common Share at a price of $1.02 for a period of two years from issuance.

This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold in the United States or to U.S. Persons unless registered under the U.S. Securities Act and any applicable state securities laws or an exemption from such registration is available.

ABOUT SPECTRA7 MICROSYSTEMS INC.

Spectra7 Microsystems Inc. is a high-performance analog semiconductor company delivering unprecedented bandwidth, speed, and resolution to enable disruptive industrial design for leading electronics manufacturers in data centers, 5G infrastructure, virtual and augmented reality, and other connectivity markets. Spectra7 is based in San Jose, California with a design center in Cork, Ireland and technical support location in Dongguan, China. For more information, please visit www.spectra7.com.

Neither the TSX Venture Exchange nor its regulation services provided (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTES

Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, the Company's anticipated closing date of a second tranche of the Offering and the Company's ability to sell the remaining Debentures in the Offering, the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's annual information form for the year ended December 31, 2021. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.

For more information, please contact:

Matt Kreps/Jim Fanucchi
Darrow Associates
214-597-8200
ir@spectra7.com

Spectra7 Microsystems Inc.
Bonnie Tomei
Chief Financial Officer
669-212-1089
ir@spectra7.com

Spectra7 Microsystems Inc.
John Mitchell
Public Relations
650-269-3043
pr@spectra7.com

 

SOURCE Spectra7 Microsystems Inc.

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2022/26/c7176.html